Suche | SocioMint

Rohit Moree hat ein neuen Blog hinzugefügt Andere
2026-07-31 12:34:43 -

Antisense Oligonucleotide for Cardiometabolic Disorders Market Advances with Growing Innovation in Precision Genetic Therapies
According to the latest report published by Data Bridge Market Research, the Antisense Oligonucleotide for Cardiometabolic Disorders Market The global antisense oligonucleotide for cardiometabolic disorders market size was valued at USD 310.32 million in 2024 and is expected to reach USD 1,135.19 million by 2032, at a CAGR of 17.60% during the forecast period The Antisense...

0 Kommentare 0 Geteilt 2KB Ansichten 0 Bewertungen

Bitte loggen Sie sich ein, um liken, teilen und zu kommentieren!
Surbhi Dbmrr hat ein neuen Blog hinzugefügt Andere
2026-10-29 05:52:33 -

Antisense Oligonucleotide for Neuromuscular Disorders Market Size and Industry Trends - 2032
According to the latest report published by Data Bridge Market Research, the Antisense Oligonucleotide for Neuromuscular Disorders Market size is projected to grow from USD 2.03 Billion in 2024 to USD 4.87 Billion by 2032, exhibiting a CAGR of 11.50% during the forecast period 2025 - 2032. The Antisense Oligonucleotide for Neuromuscular Disorders Market document has wide-ranging...

0 Kommentare 0 Geteilt 59 Ansichten 0 Bewertungen

Bitte loggen Sie sich ein, um liken, teilen und zu kommentieren!
Priti Mrfr16 hat ein neuen Blog hinzugefügt Health
2026-09-15 10:35:43 -

Antisense Oligonucleotide Therapeutics Pipeline Insight Market – Gene-Silencing Technology Expanding Rare Disease Treatment
Market Overview The antisense oligonucleotide therapeutics pipeline insight market is expanding as this gene-silencing technology continues to demonstrate therapeutic potential across rare genetic diseases and neurological disorders. Antisense oligonucleotides work by binding to specific RNA sequences to modulate protein production, offering a targeted approach to previously untreatable genetic...

0 Kommentare 0 Geteilt 969 Ansichten 0 Bewertungen

Bitte loggen Sie sich ein, um liken, teilen und zu kommentieren!